Article Text

Download PDFPDF
Interleukin 2 targeted therapy in inflammatory bowel disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding Support for this study was received from Target-In and the Frankel Trust.

  • Competing interests SY and YS are employees of GASR Biotechnology Ltd. SY has significant equity in this company. AK and NA have no competing interests.

  • Provenance and peer review Not commissioned; externally peer reviewed.